These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 19584105)

  • 1. Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin.
    Nathwani D
    J Antimicrob Chemother; 2009 Sep; 64(3):447-53. PubMed ID: 19584105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on: Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin.
    Adriaenssens N; Goossens H; Coenen S;
    J Antimicrob Chemother; 2009 Dec; 64(6):1347. PubMed ID: 19841030
    [No Abstract]   [Full Text] [Related]  

  • 3. [Daptomycin in outpatient antimicrobial parenteral therapy].
    Cervera C; Mestres CA
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():59-63. PubMed ID: 22541978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient parenteral antimicrobial therapy: Recent developments and future prospects.
    Török ME; Chapman AL; Lessing MP; Sanderson F; Seaton RA
    Curr Opin Investig Drugs; 2010 Aug; 11(8):929-39. PubMed ID: 20721835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin.
    Enoch DA; Bygott JM; Daly ML; Karas JA
    J Infect; 2007 Sep; 55(3):205-13. PubMed ID: 17629567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient parenteral antibiotic therapy: principles and practice.
    Seaton RA; Barr DA
    Eur J Intern Med; 2013 Oct; 24(7):617-23. PubMed ID: 23602223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin for outpatient parenteral antibiotic therapy: a European registry experience.
    Seaton RA; Gonzalez-Ramallo VJ; Prisco V; Marcano-Lozada M; Gonzalez-Ruiz A; Gallegos B; Menichetti F; Loeffler J; Bouylout K; Chaves RL
    Int J Antimicrob Agents; 2013 May; 41(5):468-72. PubMed ID: 23473943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient parenteral antimicrobial therapy today.
    Paladino JA; Poretz D
    Clin Infect Dis; 2010 Sep; 51 Suppl 2():S198-208. PubMed ID: 20731577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].
    Galpérine T; Ader F; Piriou P; Judet T; Perronne C; Bernard L
    Med Mal Infect; 2006 Mar; 36(3):132-7. PubMed ID: 16580802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes with daptomycin: a post-marketing, real-world evaluation.
    Sakoulas G
    Clin Microbiol Infect; 2009 Dec; 15 Suppl 6():11-6. PubMed ID: 19917022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of daptomycin in outpatient parenteral antimicrobial therapy: a prospective and multicenter cohort study (DAPTODOM trial).
    Cervera C; Sanroma P; González-Ramallo V; García de la María C; Sanclemente G; Sopena N; Pajarón M; Segado A; Mirón M; Antón F; Basterretxea A; Cuende A; Miró JM;
    Infect Dis (Lond); 2017 Mar; 49(3):200-207. PubMed ID: 27820968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study.
    Shrestha NK; Mason P; Gordon SM; Neuner E; Nutter B; O'Rourke C; Rehm SJ
    J Antimicrob Chemother; 2014 May; 69(5):1407-15. PubMed ID: 24398341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outpatient parenteral antibiotic therapy (OPAT)].
    Štefan M; Holub M
    Cas Lek Cesk; 2016; 155(3):21-4. PubMed ID: 27256144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient parenteral antimicrobial therapy in osteoarticular infections in children.
    Maraqa NF; Gomez MM; Rathore MH
    J Pediatr Orthop; 2002; 22(4):506-10. PubMed ID: 12131449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Daptomycin in home hospitalization].
    González Ramallo VJ
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():48-54. PubMed ID: 21477704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
    Yong C; Fisher DA; Sklar GE; Li SC
    Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
    Katz DE; Lindfield KC; Steenbergen JN; Benziger DP; Blackerby KJ; Knapp AG; Martone WJ
    Int J Clin Pract; 2008 Sep; 62(9):1455-64. PubMed ID: 18662172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center.
    Heintz BH; Halilovic J; Christensen CL
    Ann Pharmacother; 2011 Nov; 45(11):1329-37. PubMed ID: 21990938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey.
    Chary A; Tice AD; Martinelli LP; Liedtke LA; Plantenga MS; Strausbaugh LJ;
    Clin Infect Dis; 2006 Nov; 43(10):1290-5. PubMed ID: 17051494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.